Lab Report Review — Nighat Parveen (40 yo, Female)

1. Complete Blood Picture — SAMI Clinical Lab, 22 Aug 2026

Test	Result	Reference (Female)	Status
TLC	5,600 /µL	4,500–11,000	Normal
RBC count	4.93 x10⁶/µL	4.2–5.4	Normal
Hemoglobin	12.5 g/dL	12.0–16.0	Normal (low-normal)
PCV/HCT	37.69%	36–46	Normal
MCV	76.4 fL	80–100	Low
MCH	25.3 pg	26–34	Low
MCHC	33.2 g/dL	31–37	Normal
Platelets	231,000 /µL	140,000–440,000	Normal
ESR / Retic count	Not performed	—	—
Neutrophils	57%	54–62	Normal
Lymphocytes	34%	25–33	Mildly high
Monocytes	5%	3–7	Normal
Eosinophils	4%	1–6	Normal
Basophils	0%	0–0.75	Normal

Interpretation: Hemoglobin, hematocrit, and RBC count are all within normal limits — there is no overt anemia. However, both MCV and MCH are reduced, giving a microcytic, hypochromic red-cell picture despite a normal hemoglobin. This combination (normal Hb with low MCV/MCH) is a classic pattern of either:

Early/latent iron deficiency (red cell size/content drops before Hb falls), or
Thalassemia trait (minor) — heterozygous carriers commonly have normal or borderline Hb with disproportionately low MCV/MCH.

Distinguishing the two matters because thalassemia trait carries genetic-counseling implications, while iron deficiency needs replacement and a search for the underlying cause (e.g., menstrual blood loss, dietary deficiency, GI losses) - Robbins & Cotran, Pathologic Basis of Disease. The next logical step is iron studies (serum iron, ferritin, TIBC/transferrin saturation); if these are normal despite the microcytosis, hemoglobin electrophoresis/HbA2 should be checked to rule out thalassemia minor - Scott-Brown's Otorhinolaryngology; Frameworks for Internal Medicine.

Lymphocytes are marginally above the upper reference limit (34% vs 33%), but the absolute lymphocyte count (~34% of 5,600 = ~1,900/µL) is well within the normal adult range, so this is not clinically significant on its own — it can reflect a recent/resolving mild viral illness or simple lab-to-lab variability rather than a hematologic disease - Goldman-Cecil Medicine.

ESR and reticulocyte count were not performed on this report, so the full anemia work-up is incomplete — these (plus iron studies) would help confirm or exclude iron deficiency.

2 & 3. Thyroid Panel — Labcorp/Sami Lab Mianwali, 23 Aug 2026

Test	Result	Adult Reference (21–54 yrs)	Status
T3	1.18 ng/mL	0.70–2.04	Normal
T4	77.7 nmol/L	59.2–142.0	Normal
TSH	3.55 µIU/mL	0.35–4.94	Normal

Interpretation: TSH is the most sensitive initial screen for thyroid dysfunction; a normal TSH together with normal T3 and T4 confirms a euthyroid state - Washington Manual of Medical Therapeutics; Kaplan & Sadock's Comprehensive Textbook of Psychiatry. There is no biochemical evidence of hypothyroidism, subclinical hypothyroidism, or hyperthyroidism. The TSH of 3.55 sits in the upper-middle of the normal range but is not elevated beyond the reference ceiling (4.94), so it does not meet criteria for subclinical hypothyroidism (which requires TSH above range with a normal free T4).

Overall Summary

Blood counts: No anemia, but a microcytic/hypochromic red cell pattern (low MCV, low MCH) with normal Hb — most consistent with early iron deficiency or thalassemia trait. Recommend iron profile ± ferritin, and hemoglobin electrophoresis if iron studies are normal. Given the patient is a 40-year-old woman, ask about menstrual history/blood loss as a common contributing cause.
WBC/differential: Essentially normal; borderline lymphocyte percentage is not clinically worrying given a normal absolute count.
Platelets: Normal.
Thyroid function: T3, T4, and TSH are all normal — the patient is euthyroid with no evidence of thyroid disease.

I checked PubMed for very recent systematic reviews on iron-deficiency red-cell indices, but the top hits were not clinically relevant to this case (athlete iron deficiency, veterinary studies, ophthalmology) — no contradicting recent evidence to flag.

Bottom line: No acute abnormality demanding urgent action. The one point worth pursuing clinically is the microcytic/hypochromic indices with normal hemoglobin — an iron panel (and thalassemia screen if iron studies are unremarkable) would clarify whether this represents latent iron deficiency or a hemoglobinopathy trait. Thyroid function is entirely normal.

Patient has heavy periods

Finding Sources

Searching PubMed

"heavy menstrual bleeding" AND "iron deficiency"

Updated Interpretation — With History of Heavy Periods (Menorrhagia)

This clinical detail fits well with the lab picture and essentially confirms the leading hypothesis from the CBC.

Why this matters for her CBC:

Heavy menstrual bleeding is defined as >80 mL blood loss per cycle - the amount of loss required to actually produce iron-deficiency anemia over time - Harrison's Principles of Internal Medicine, 22nd Ed.
Menstruating women normally lose about 30 mg of iron per period; women with heavy menstrual bleeding lose substantially more and are the classic population who develop iron deficiency, often before hemoglobin even drops - Katzung's Basic and Clinical Pharmacology.
This lines up exactly with her CBC: normal Hb (12.5 g/dL) and normal RBC count, but low MCV (76.4) and low MCH (25.3) - a microcytic/hypochromic pattern with no anemia yet. This is the textbook signature of early/latent iron deficiency from chronic blood loss, more likely than thalassemia trait now that a clear source of ongoing blood loss (menorrhagia) is identified.

Recommended next steps:

Iron studies - serum ferritin, serum iron, TIBC/transferrin saturation. Ferritin is the most reliable single marker; a ferritin under ~30 ng/mL (or under 100 with transferrin saturation <20%) confirms iron deficiency - Tietz Textbook of Laboratory Medicine; Rosen's Emergency Medicine.
Gynecologic evaluation of the heavy bleeding itself - causes in a 40-year-old woman commonly include anovulatory cycles/perimenopausal irregularity, fibroids, adenomyosis, endometrial polyps, or (less commonly at this age) a bleeding disorder such as von Willebrand disease, which is associated with heavy menstrual bleeding in up to 80% of affected women - Goldman-Cecil Medicine; Textbook of Family Medicine. A pelvic ultrasound and possibly coagulation screen would be reasonable if bleeding is significant.
If ferritin/iron confirm deficiency: start oral iron replacement (ferrous sulfate or similar); recheck Hb/ferritin in 4-6 weeks to confirm response - Textbook of Family Medicine; Goldman-Cecil Medicine.
For the heavy bleeding itself: first-line medical options include tranexamic acid (1.3 g three times daily during menses) or hormonal therapy (combined oral contraceptives or a levonorgestrel IUD), which reduce menstrual blood loss and secondarily prevent recurrent iron deficiency - Berek & Novak's Gynecology.
Her thyroid panel remains reassuring (T3, T4, TSH all normal) - hypothyroidism is itself a recognized cause of heavy menstrual bleeding, and that has now been excluded, which actually strengthens the case that the bleeding is a primary gynecologic/structural or anovulatory issue rather than endocrine.

A recent systematic review and meta-analysis (Comishen et al., 2025, J Thromb Haemost, PMID 39617186) on the etiology and diagnosis of heavy menstrual bleeding supports this same stepped approach - excluding structural/endocrine causes and screening for bleeding disorders when heavy menstrual bleeding is confirmed, particularly given the associated risk of iron deficiency. This doesn't contradict the textbook guidance above, just reinforces it.

Bottom line: Her blood counts and thyroid tests are not abnormal enough to be alarming today, but the combination of low MCV/MCH with a history of heavy periods strongly suggests she is in the early stage of iron-deficiency from menstrual blood loss. Getting a ferritin/iron panel now, and addressing the heavy bleeding gynecologically, would both treat the underlying cause and prevent her from progressing to overt iron-deficiency anemia.

Now tell me what treatment I should recommend her or which things or advice should I suggest

Finding Sources

Searching PubMed

"heavy menstrual bleeding" AND management

Treatment & Advice Plan — Nighat Parveen (40F, Heavy Periods + Microcytic Indices)

1. Confirm the Diagnosis First (before treating)

Serum ferritin, iron, TIBC/transferrin saturation — confirms iron deficiency and gives a baseline to monitor response to treatment.
Pelvic ultrasound — to look for fibroids, polyps, or adenomyosis as a structural cause of the heavy bleeding.
Endometrial biopsy — recommended in the workup of abnormal uterine bleeding even in premenopausal women; guidelines note about 5% of endometrial cancer cases occur under age 40, so this shouldn't be skipped just because she's premenopausal - Berek & Novak's Gynecology; Schwartz's Principles of Surgery.
Consider a coagulation screen/von Willebrand work-up if bleeding is severe, lifelong, or there's a bleeding history (easy bruising, epistaxis, family history) - Goldman-Cecil Medicine.

2. Treat the Iron Deficiency

Oral iron replacement: ferrous sulfate 325 mg (65 mg elemental iron) once or twice daily is a reasonable starting dose; standard adult treatment ranges from 60-200 mg elemental iron/day in divided doses, taken on an empty stomach or with vitamin C to improve absorption - Goodman & Gilman's Pharmacology; Katzung's Basic and Clinical Pharmacology.
Advise on tolerability: constipation, dark stools, GI upset are common — taking with food (slightly reduces absorption but improves tolerance) or switching to alternate-day dosing helps.
Recheck Hb and ferritin in 4-6 weeks; ferritin should be checked again after any correction to confirm stores have been replenished, not just Hb normalized.
Dietary advice: iron-rich foods (red meat, liver, leafy greens, legumes), pair with vitamin C-rich foods, avoid tea/coffee with iron-containing meals (tannins reduce absorption).
If she cannot tolerate/absorb oral iron, or deficiency is severe, IV iron is an option — discuss with her physician.

3. Treat the Heavy Menstrual Bleeding Itself (this is the actual driver — treating iron alone without fixing this will just cause recurrence)

First-line medical options (non-hormonal or hormonal, guided by her fertility wishes and any contraindications):

Option	Notes
Tranexamic acid	1.3 g three times daily during menses (up to 5 days), non-hormonal antifibrinolytic — reduces menstrual blood loss significantly, FDA-approved for menorrhagia - Berek & Novak's Gynecology; Tintinalli's Emergency Medicine
NSAIDs (e.g. mefenamic acid)	Taken during bleeding days; reduces flow and also helps cramping, though effect is milder than tranexamic acid or hormonal options - Goodman & Gilman's Pharmacology
Levonorgestrel-releasing IUD (LNG-IUS)	Considered first-line medical treatment for heavy menstrual bleeding, including when fibroids are present; can be left in place for years, also gives contraception - Berek & Novak's Gynecology; Textbook of Family Medicine (ACOG, Grade B)
Combined oral contraceptives	Regulate and lighten cycles, reasonable if she has no contraindications (smoking, migraine with aura, clotting risk, etc.)

If bleeding is due to structural pathology (fibroids/polyps found on ultrasound): treatment may need to be tailored — e.g., polypectomy, myomectomy, or referral to gynecology. A 2024 Canadian practice guideline (JOGC, Leyland et al., PMID 39168283) discusses endometrial ablation as an option for women who have completed childbearing and fail medical therapy — worth keeping in mind if she doesn't want more children and doesn't respond to the above.

4. General Advice to Give the Patient

Track her bleeding (pad/tampon count, clots, duration) — this helps objectively assess whether treatment is working.
Report any dizziness, palpitations, severe fatigue, or shortness of breath — signs that anemia may be worsening and needs urgent reassessment.
Continue thyroid monitoring is not needed right now since her panel is normal, but if bleeding pattern changes or she develops new symptoms, thyroid function can be a contributing factor and may need to be rechecked in future.
Reinforce that iron pills alone won't fix the root problem — she needs both the iron replacement and a plan to control the heavy bleeding, otherwise she'll keep sliding back into deficiency.
If she desires pregnancy, mention this before initiating hormonal treatments (LNG-IUS/COCP) — tranexamic acid or NSAIDs would be preferred non-hormonal choices in that case.

Referral Threshold

Refer to gynecology if:

Ultrasound shows fibroids/polyps/structural abnormality needing procedural management
Bleeding fails to respond to tranexamic acid/NSAIDs/hormonal therapy after 2-3 cycles
Endometrial biopsy is indicated (age, risk factors, or persistent abnormal bleeding)
Suspicion of a bleeding disorder (family history, other bleeding symptoms)

This is a systematic-review-supported approach (Comishen et al. 2025, J Thromb Haemost, PMID 39617186, on etiology/diagnosis pathway for heavy menstrual bleeding) combined with standard textbook management (iron repletion + antifibrinolytic/hormonal control of bleeding + structural work-up). Nothing in the recent literature I checked contradicts this stepped approach.

This is a shared conversation. Sign in to Orris to start your own chat.